Issue 16, 2015

Targeting cancer cells using aptamers: cell-SELEX approach and recent advancements

Abstract

Aptamers are short single stranded nucleic acid molecules, isolated from a pool of nucleic acid molecules by the method called SELEX (Systematic Evolution of Ligands by EXponential Enrichment) that can bind to the target with high affinity and specificity. A modified SELEX method where the targets are living whole cells is referred as cell-SELEX, and is of great interest because it opens up a simple and effective method for disease diagnostics and therapeutics. The cell-SELEX based approach and recent developments of the technique for identifying aptamers as well as their application in cancer diagnostics and therapeutics are summarized here.

Graphical abstract: Targeting cancer cells using aptamers: cell-SELEX approach and recent advancements

Article information

Article type
Review Article
Submitted
15 Oct 2014
Accepted
12 Jan 2015
First published
12 Jan 2015

RSC Adv., 2015,5, 11724-11732

Author version available

Targeting cancer cells using aptamers: cell-SELEX approach and recent advancements

J. Barman, RSC Adv., 2015, 5, 11724 DOI: 10.1039/C4RA12407C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements